FLINT, Mich. — May 22, 2017 — Diplomat Pharmacy, Inc. (NYSE: DPLO) will be hosting its second Analyst and Investor Day on Tuesday, June 27, 2017 in New York City.

The nation’s largest independent provider of specialty pharmacy services will provide industry insight and outline strategies for how the company will drive long-term growth and shareholder value. Panel discussions will feature external pharmaceutical manufacturer, payor, and consultant business partners and Diplomat executives.

A live audio-only webcast of Diplomat’s Analyst and Investor Day and related presentation materials will be available on the investor relations section of the company’s website at ir.diplomat.is. Following the event, presentation materials and an audio file will be archived for 90 days at ir.diplomat.is.

About Diplomat

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.

Bob East, Westwicke Partners
443.213.0500 | diplomat@westwicke.com

Jenny Cretu, Diplomat
810.768.9370 | jcretu@diplomat.is